Alerts in the last 24 hours

No Personalised Alerts!

To see personalised alerts you need to be logged in.

Log In

Shire PLC Add to portfolio

LON100:SHP, Sep 26, 09:41 UTC

Latest LON100:SHP News

Filter your feed

Apply Filter

Friday, September 21


News

Is Shire (SHPG) a Suitable Stock for Value Investors Now?

SHP

After all, who wouldn’t want to find stocks that are either flying under the radar and are compelling buys, or offer up tantalizing discounts when compared to fair value?One way to find these companies is by looking at several key metrics and financial ratios, many of which are crucial in the value stock selection process. This shows us how much investors are willing to pay for each dollar of earnings in a given stock, and is easily one of the most popular financial ratios in the world. The best use of the PE ratio is to compare the stock’s current PE ratio with: a) where this ratio has been in the past; b) how it compares to the average for the industry/sector; and c) how it compares to the market as a whole.On this front, Shire has a trailing twelve months PE ratio of 11.6, as you can see in the chart below:This level actually compares pretty favorably with the market at large, as the PE for the S&P 500 stands at about 20.1. If we focus on the long-term PE trend, Shire’s current PE level puts it below its midpoint over the past five years. This approach compares a given stock’s price to its total sales, where a lower reading is generally considered better. Some people like this metric more than other value-focused ones because it looks at sales, something that is far harder to manipulate with accounting tricks than earnings.Right now, Shire has a P/S ratio of about 3.6.

Read Full Details

Topics:
  • Business
  • Financial
News

Shire plc: Rule 2.9 Announcement

SHP

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF THAT JURISDICTION. In accordance with Rule 2.9 of the City Code on Takeovers and Mergers, the Company confirms that, as at the close of business on 20 September 2018, being the last business day prior to the date of this announcement, it had 922,032,804 ordinary shares of 5 pence each in issue and admitted to trading on the main market of the London Stock Exchange. Accordingly, the total number of voting rights in Shire is 914,675,521. The International Securities Identification Number (“ISIN”) for Shire’s ordinary shares is JE00B2QKY057.

Read Full Details

Topics:
  • Business
  • Financial
News

Shire Receives Approval of FIRAZYR® (icatibant injection) for the Treatment of Hereditary Angioedema (HAE) Attacks in Japan

SHP

The areas of the body most commonly affected are the extremities, skin, gastrointestinal tract and, less frequently, HAE can cause life-threatening attacks due to obstruction in the upper airways. Symptoms of HAE often present in childhood, and while attacks can occur at any age, early onset may predict a more severe disease course. “HAE attacks can be unpredictable and debilitating and we are delighted that, subject to price listing, we will be able to provide the Japanese HAE community with the first subcutaneous on-demand therapy to treat acute HAE attacks.”. For most people, attacks of HAE are caused by a deficiency of a protein called C1-esterase-inhibitor (C1-INH), either there is not enough of it or it does not function properly. Use in the Elderly Elderly patients (≥65 years) are likely to have increased systemic exposure to FIRAZYR compared to younger (18-45 years) patients.

Read Full Details

Topics:
  • Business
  • Health
  • Financial

Thursday, September 20


News

Shire’s Quarterly Revenue Trend

SHP

Biotechnology company Shire (SHPG) reported a 4.6% YoY (year-over-year) rise in revenue to ~$3.9 billion in the second quarter compared to $3.7 billion in the second quarter of 2017.

Read Full Details

Topics:
  • Business
  • Financial
News

Merrimack Receives $5 Million Milestone Payment from Shire

SHP

The terms of the Company's asset sale to Ipsen in 2017 entitled Merrimack to receive up to an aggregate of $33.0 million in net milestone payments from Shire, of which Merrimack has now received $23.0 million, including this milestone and the $18.0 million payment in August 2018 resulting from the sale of ONIVYDE in two additional major European countries. Merrimack has stated it expects to pass these proceeds through to stockholders, net of any taxes owed and subject to there being a sufficient surplus at that time, consisting of:. All of Merrimack's development programs, including three clinical studies and six candidates in preclinical development, fit into its strategy of 1) understanding the biological problems it is trying to solve, 2) designing specific solutions and 3) developing those solutions for biomarker-selected patients. Merrimack undertakes no obligation to update or revise any forward-looking statements. Forward-looking statements should not be relied upon as representing Merrimack's views as of any date subsequent to the date hereof. For a further description of the risks and uncertainties that could cause actual results to differ from those expressed in these forward-looking statements, as well as risks relating to Merrimack's business in general, see the "Risk Factors" section of Merrimack's Quarterly Report on Form 10-Q filed with the SEC on August 7, 2018 and the other reports Merrimack files with the SEC.

Read Full Details

Topics:
  • Business
  • Health
  • Financial
News

Shire plc: Rule 2.9 Announcement

SHP

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF THAT JURISDICTION. In accordance with Rule 2.9 of the City Code on Takeovers and Mergers, the Company confirms that, as at the close of business on 19 September 2018, being the last business day prior to the date of this announcement, it had 922,009,953 ordinary shares of 5 pence each in issue and admitted to trading on the main market of the London Stock Exchange. Accordingly, the total number of voting rights in Shire is 914,652,670. The International Securities Identification Number (“ISIN”) for Shire’s ordinary shares is JE00B2QKY057.

Read Full Details

Topics:
  • Business
  • Financial

Tuesday, September 18


News

Shire plc: Rule 2.9 Announcement London Stock Exchange:SHP

SHP

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF THAT JURISDICTION. In accordance with Rule 2.9 of the City Code on Takeovers and Mergers, the Company confirms that, as at the close of business on 17 September 2018, being the last business day prior to the date of this announcement, it had 921,991,968 ordinary shares of 5 pence each in issue and admitted to trading on the main market of the London Stock Exchange. Accordingly, the total number of voting rights in Shire is 914,634,685. The International Securities Identification Number (“ISIN”) for Shire’s ordinary shares is JE00B2QKY057.

Read Full Details

Topics:
  • Business
  • Financial
  • Science

Monday, September 17


News

Shire plc: Rule 2.9 Announcement

SHP

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF THAT JURISDICTION. In accordance with Rule 2.9 of the City Code on Takeovers and Mergers, the Company confirms that, as at the close of business on 14 September 2018, being the last business day prior to the date of this announcement, it had 921,964,257 ordinary shares of 5 pence each in issue and admitted to trading on the main market of the London Stock Exchange. Accordingly, the total number of voting rights in Shire is 914,606,974. The International Securities Identification Number (“ISIN”) for Shire’s ordinary shares is JE00B2QKY057.

Read Full Details

Topics:
  • Business
  • Financial
  • Science

Friday, September 14


News

FTSE tracks Europe higher; Shire shines

SHP TRI

* Shire (Xetra: S7E.DE - news) gains after China nod to Takeda deal. MILAN, Sept 14 (Reuters) - Britain's top share index tracked higher European markets on Friday with the mood buoyed by easing trade worries, while Shire rose after China cleared Takeda's plans to buy the drugmaker. The FTSE 100 ended up 0.3 percent, underpinned by gains among industrials and materials sectors, which more than offset weakness among utilities, hit earlier this week by a profit warning from SSE (LSE: SSE.L - news) . President Donald Trump said on Thursday that the United (Shenzhen: 000925.SZ - news) States was under no pressure to make a trade deal with China, even as Chinese officials welcomed an invitation from Washington for a new round of talks with more U.S. tariffs looming.

Read Full Details

Topics:
  • Business
  • Financial
News

Form 8.3 - Shire plc

SHP

Business Wire14 September 2018, 14:31 GMT. FORM 8.3. (e) Date position held/dealing undertaken:. For an opening position disclosure, state the latest practicable date prior to the disclosure. Glenview shorted 5,064,634 shares of Shire plc as part of a process to reduce its long position exposure which is currently held in ADR securities. As part of the settlement process, an amount of ADRs equal to 5,064,634 ordinary shares will be used to cover the short sale thereby reducing Glenview’s long exposure. Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the person making the disclosure and any party to the offer or any person acting in concert with a party to the offer:.

Read Full Details

Topics:
  • Business
  • Financial